(Q42937602)

11 November 2017

0 references

Editorial commentary: fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance (English)

1 reference

11 November 2017

1 reference

1

1 reference

11 November 2017

Jenny M MacLennan

2

1 reference

PMC publication ID

4191561

11 November 2017

language of work or name

English

0 references

publication date

28 July 2014

1 reference

Clinical Infectious Diseases

11 November 2017

1 reference

11 November 2017

59

1 reference

11 November 2017

9

1 reference

11 November 2017

1222-1224

1 reference

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Effectiveness of meningococcal serogroup C vaccine programmes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Accelerating next-generation vaccine development for global disease prevention

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

The endgame for serogroup a meningococcal disease in Africa?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Can we, should we, eradicate the meningococcus?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Meningococcal carriage by age: a systematic review and meta-analysis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Meningococcal C conjugate vaccine: the experience in England and Wales

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Meningococcal carriage and disease--population biology and evolution

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Human immunity to the meningococcus. I. The role of humoral antibodies

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Group B meningococcal vaccine: recommendations for UK use.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4191561

Meningococcal conjugate vaccines: new opportunities and new challenges

30 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIU599

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIU599

A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination

21 January 2018

1 reference

12 December 2020

Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands

1 reference

12 December 2020

Introducing a new group B meningococcus vaccine

1 reference

12 December 2020

No conspiracy regarding recommendation for a group B meningococcus vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIU599

1 reference

11 November 2017

1 reference

PMC publication ID

4191561

11 November 2017

PubMed publication ID

25069870

1 reference

PMC publication ID

4191561